Art

J-GLOBAL ID：202102267721364173   Reference number：21A0287851

Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders

神経発達障害児の睡眠問題と異常行動に対する長期メラトニン治療【JST・京大機械翻訳】

Author (10)： Yuge Kotaro (Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan) ,  Nagamitsu Shinichiro (Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan) ,  Ishikawa Yuko (Nobelpharma Co., Ltd., Tokyo, Japan) ,  Hamada Izumi (Nobelpharma Co., Ltd., Tokyo, Japan) ,  Takahashi Hiroyuki (CMIC Co., Ltd., Tokyo, Japan) ,  Sugioka Hideyuki (Nobelpharma Co., Ltd., Tokyo, Japan) ,  Yotsuya Osamu (Nobelpharma Co., Ltd., Tokyo, Japan) ,  Mishima Kazuo (Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan) ,  Hayashi Masaharu (Department of Nursing, College of Nursing and Nutrition, Shukutoku University, Chiba, Japan) ,  Yamashita Yushiro (Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan)
Material： BMC Psychiatry (Web)
Volume： 20  Issue： 1  Page： 1-14  Publication year： 2020 
JST Material Number： U7447A  ISSN： 1471-244X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Clinical evidence is required ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0287851&from=J-GLOBAL&jstjournalNo=U7447A") }}

Thesaurus term： standard deviation ,  drug therapy ,  clinical trial ,  *child ,  Arousal ,  movement disorder ,  intelligence disorder ,  screening (inspection) ,  learning disorder ,  communicative disorder ,  Sleepiness ,  end point ,  adverse reaction ,  fatty acid ,  nitrogen heterocyclic compound ,  carboxamide ,  phenol ether ,  polynuclear aromatic compound
Semi thesaurus term： 自閉症スペクトラム障害 ,  有害事象 , 【Automatic Indexing@JST】

Author keywords (7)： Melatonin ,  Neurodevelopmental disorders ,  Sleep onset latency ,  Children ,  Sleep problems ,  Aberrant behaviors ,  Long-term

JST classification (5)： Clinical application of psychotropic drugs  (GW03110J) ,  Mental disorders  (GR03000A) ,  Clinical psychiatry in general  (GR01030T) ,  Diseases specific to children  (GC08020M) ,  Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Substance index (1)： Melatonin

Reference (43)：

• Curr Neuropharmacol; Melatonin: pharmacology, functions and therapeutic benefits; S Tordjman, S Chokron, R Delorme, A Charrier, E Bellissant, N Jaafari; 15; 3; 2017; 434-443; citation_id=CR1
• N Engl J Med; Melatonin in humans; A Brzezinski; 336; 3; 1997; 186-195; citation_id=CR2
• J Physiol Pharmacol; Melatonin in humans; M Karasek, K Winczyk; 57; Suppl 5; 2006; 19-39; citation_id=CR3
• J Biol Rhythm; Melatonin: characteristics, concerns, and prospects; J Arendt; 20; 4; 2005; 291-303; citation_id=CR4
• Acta Paediatr; Sleep problems of school-aged children: a complementary view; EJ Paavonen, ET Aronen, I Moilanen, J Piha, E Räsänen, T Tamminen; 89; 2; 2000; 223-228; citation_id=CR5

Terms in the title (6)： 神経発達障害 ,  睡眠 ,  異常行動 ,  長期 ,  メラトニン ,  治療